European Healthcare Acquisition & Growth Company B.V Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Cornelius Baur
Chief executive officer
€242.5k
Total compensation
CEO salary percentage | 96.9% |
CEO tenure | 2.6yrs |
CEO ownership | 6.3% |
Management average tenure | no data |
Board average tenure | 2.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | €243k | €235k | €26m |
Sep 30 2023 | n/a | n/a | €12m |
Jun 30 2023 | n/a | n/a | -€3m |
Mar 31 2023 | n/a | n/a | -€17m |
Dec 31 2022 | €484k | €470k | -€30m |
Dec 31 2021 | €119k | €57k | -€5m |
Compensation vs Market: Cornelius's total compensation ($USD259.56K) is below average for companies of similar size in the German market ($USD780.88K).
Compensation vs Earnings: Cornelius's compensation has been consistent with company performance over the past year.
CEO
Cornelius Baur (62 yo)
2.6yrs
Tenure
€242,505
Compensation
Dr. Cornelius Baur is Member of the Supervisory Board of Lenzing Aktiengesellschaft from April 18, 2024. Dr. Baur is Chief Executive Officer & Director of European Healthcare Acquisition & Growth Company B...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 2.6yrs | €242.51k | 6.33% € 13.3m | |
Chief Investment Officer | 2.5yrs | €241.61k | 6.33% € 13.3m | |
Non-Executive Director | 2.6yrs | €20.00k | 6.33% € 13.3m | |
Independent Vice Chairman of the Board | 2.6yrs | €20.00k | 6.33% € 13.3m | |
Non-Executive Chairman of the Board | 2.6yrs | €120.00k | 1.67% € 3.5m | |
Independent Non-Executive Director | 2.6yrs | €20.00k | 6.33% € 13.3m |
2.6yrs
Average Tenure
60.5yo
Average Age
Experienced Board: QX0's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.